Werbung
Werbung

CRMD

CRMD logo

CorMedix Inc.

7.63
USD
Gesponsert
+0.12
+1.57%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

7.63

0.00
-0.04%

CRMD Ergebnisberichte

Positives Überraschungsverhältnis

CRMD übertreffen die 25 der letzten 40Schätzungen.

63%

Nächster Bericht

Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$130.07M
/
$0.85
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+24.74%
/
-32.54%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+316.78%
/
+286.36%

CorMedix Inc. earnings per share and revenue

On 12. Nov. 2025, CRMD reported earnings of 1.26 USD per share (EPS) for Q3 25, beating the estimate of 0.65 USD, resulting in a 91.46% surprise. Revenue reached 104.28 million, compared to an expected 87.74 million, with a 18.84% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.85 USD, with revenue projected to reach 130.07 million USD, implying an decrease of -32.54% EPS, and increase of 24.74% in Revenue from the last quarter.
FAQ
For Q3 2025, CorMedix Inc. reported EPS of $1.26, beating estimates by 91.46%, and revenue of $104.28M, 18.84% above expectations.
The stock price moved up 2.06%, changed from $11.19 before the earnings release to $11.42 the day after.
The next earning report is scheduled for 23. März 2026.
Based on 9 analysts, CorMedix Inc. is expected to report EPS of $0.85 and revenue of $130.07M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung